GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GamLPV (intranasal Bordetella pertussis vaccine) / Gamaleya Research Institute
NCT03137927: A Phase I Clinical Study of a GamLPV, a Live Intranasal Bordetella Pertussis Vaccine

Completed
1
36
RoW
Vaccine GamLPV, live intranasal Bordetella pertussis vaccine, Placebo
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Whooping Cough
12/17
12/17

Download Options